A rare adverse effect of montelukast treatment: ecchymosis

Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after startin...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory care 2013-09, Vol.58 (9), p.e104-e106
Main Authors: Aypak, Cenk, Türedi, Özlem, Solmaz, Nisa, Yıkılkan, Hülya, Görpelioğlu, Süleyman
Format: Article
Language:English
Subjects:
Acetates - administration & dosage
Acetates - adverse effects
Adult
Adverse and side effects
Anti-inflammatory drugs
Asthma
Complications and side effects
Drug therapy
Drugs
Ecchymosis - chemically induced
Female
Humans
Leukotriene Antagonists - administration & dosage
Leukotriene Antagonists - adverse effects
Lower Extremity
Montelukast
Patient outcomes
Quinolines - administration & dosage
Quinolines - adverse effects
Rhinitis, Allergic, Seasonal - drug therapy
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued.
ISSN:0020-1324
1943-3654
DOI:10.4187/respcare.02298